Immune Pharmaceuticals, Inc. Appoints Gad Berdugo To Board Of Directors And Karin Hehenberger, M.D., Ph.D To Senior Vice President
6/6/2014 9:29:09 AM
NEW YORK and HERZLIYA-PITUACH, Israel, June 6, 2014 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals Inc. (OTCQX:IMNP) (Nasdaq:IMNP) ("Immune" or "the Company") appointed Mr. Gad Berdugo as new independent director and Karin Hehenberger, M.D., Ph.D., as Senior Vice President, Medical Affairs and Corporate Communications.
Help employers find you! Check out all the jobs and post your resume.
comments powered by